Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE Trial.
Samuel M, Khairy P, Mongeon FP, Andrade JG, Gomes S, Galvan Z, Weerasooriya R, Novak P, Nault I, Arentz T, Deisenhofer I, Veenhuyzen GD, Jaïs P, Parkash R, Verma A, Menon S, Puererfellner H, Scavée C, Talajic M, Guerra PG, Rivard L, Dubuc M, Dyrda K, Thibault B, Mondesert B, Tadros R, Cadrin-Tourigny J, Aguilar M, Tardif JC, Levesque S, Roy D, Nattel S, Macle L.
Samuel M, et al. Among authors: tardif jc.
Can J Cardiol. 2020 Dec;36(12):1965-1974. doi: 10.1016/j.cjca.2020.10.013. Epub 2020 Nov 3.
Can J Cardiol. 2020.
PMID: 33157186
Clinical Trial.
Although the results are encouraging for the safety of AF ablation, 20.8% of patients had mild or moderate PV stenosis, in which the long-term effects are unknown....
Although the results are encouraging for the safety of AF ablation, 20.8% of patients had mild or moderate PV stenosis, in which the long- …